The Center for Biosimilars recaps the top 5 stories in biosimilar news for the week of July 3, 2017.
Where clinical, regulatory, and economic perspectives converge—sign up for Center for Biosimilars® emails to get expert insights on emerging treatment paradigms, biosimilar policy, and real-world outcomes that shape patient care.